4,4-二甲基-7-硝基-1,2,3,4-四氢喹啉
4,4-二甲基-7-硝基-1,2,3,4-四氢喹啉结构式
|
常用名 | 4,4-二甲基-7-硝基-1,2,3,4-四氢喹啉 | 英文名 | Quinoline, 1,2,3,4-tetrahydro-4,4-dimethyl-7-nitro- |
|---|---|---|---|---|
| CAS号 | 561297-83-4 | 分子量 | 206.24100 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C11H14N2O2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 4,4-二甲基-7-硝基-1,2,3,4-四氢喹啉 |
|---|---|
| 英文名 | 4,4-Dimethyl-7-nitro-1,2,3,4-tetrahydroquinoline |
| 英文别名 | 更多 |
| 分子式 | C11H14N2O2 |
|---|---|
| 分子量 | 206.24100 |
| 精确质量 | 206.10600 |
| PSA | 57.85000 |
| LogP | 3.34920 |
| 海关编码 | 2933499090 |
|---|
|
~50%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ; Title/Abstract Full Text Show Details Vertex Pharmaceuticals Incorporated Patent: US2012/309758 A1, 2012 ; US 20120309758 A1 |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：AMGEN INC. Patent: WO2007/48070 A2, 2007 ; Location in patent: Page/Page column 124 ; |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Higuchi, Robert I.; Edwards, James P.; Caferro, Thomas R.; Ringgenberg, Josef D.; Kong, James W.; Hamann, Lawrence G.; Arienti, Kristen L.; Marschke, Keith B.; Davis, Robert L.; Farmer, Luc J.; Jones, Todd K. Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 9 p. 1335 - 1340 |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Vertex Pharmaceuticals Incorported Patent: US2011/98311 A1, 2011 ; |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Higuchi, Robert I.; Edwards, James P.; Caferro, Thomas R.; Ringgenberg, Josef D.; Kong, James W.; Hamann, Lawrence G.; Arienti, Kristen L.; Marschke, Keith B.; Davis, Robert L.; Farmer, Luc J.; Jones, Todd K. Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 9 p. 1335 - 1340 |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Higuchi, Robert I.; Edwards, James P.; Caferro, Thomas R.; Ringgenberg, Josef D.; Kong, James W.; Hamann, Lawrence G.; Arienti, Kristen L.; Marschke, Keith B.; Davis, Robert L.; Farmer, Luc J.; Jones, Todd K. Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 9 p. 1335 - 1340 |
|
~%
4,4-二甲基-7-硝基-1,... 561297-83-4 |
| 文献：Higuchi, Robert I.; Edwards, James P.; Caferro, Thomas R.; Ringgenberg, Josef D.; Kong, James W.; Hamann, Lawrence G.; Arienti, Kristen L.; Marschke, Keith B.; Davis, Robert L.; Farmer, Luc J.; Jones, Todd K. Bioorganic and Medicinal Chemistry Letters, 1999 , vol. 9, # 9 p. 1335 - 1340 |
| 海关编码 | 2933499090 |
|---|---|
| 中文概述 | 2933499090. 其他含喹琳或异喹啉环系的化合物〔但未进一步稠合的〕. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| 1,2,3,4-tetrahydro-4,4-dimethyl-7-nitroquinoline |
| 1-Naphthalenol,1,2,3,4-tetrahydro-4,4-dimethyl |
| 4,4-dimethyl-1,2,3,4-tetrahydronaphthalen-1-ol |
| 1,2,3,4-tetrahydro-4,4-dimethyl-1-naphthol |
| 4,4-dimethyl-1-tetralol |
| 4,4-Dimethyl-2-hydroxy-1,2,3,4-tetrahydronaphthalin |
| 4,4-dimethyl-7-nitro-1,2,3,4-tetrahydro-quinoline |
| dimethyl-4,4 tetralol |
本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。
